Report cover image

Global Tasimelteon Market Growth 2025-2031

Published Aug 15, 2025
Length 82 Pages
SKU # LPI20313360

Description

The global Tasimelteon market size is predicted to grow from US$ 136 million in 2025 to US$ 263 million in 2031; it is expected to grow at a CAGR of 11.6% from 2025 to 2031.

Tasimelteon is a selective melatonin receptor agonist primarily used for the treatment of insomnia, particularly insomnia related to circadian rhythm disorders. It works by binding to melatonin receptors, helping to regulate the sleep-wake cycle and improve sleep quality in patients. The drug is clinically used to treat sleep problems caused by disruptions in the biological clock, such as in elderly individuals and shift workers.

United States market for Tasimelteon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tasimelteon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tasimelteon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tasimelteon players cover Vanda Pharmaceuticals, Teva Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Tasimelteon Industry Forecast” looks at past sales and reviews total world Tasimelteon sales in 2024, providing a comprehensive analysis by region and market sector of projected Tasimelteon sales for 2025 through 2031. With Tasimelteon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tasimelteon industry.

This Insight Report provides a comprehensive analysis of the global Tasimelteon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tasimelteon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tasimelteon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tasimelteon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tasimelteon.

This report presents a comprehensive overview, market shares, and growth opportunities of Tasimelteon market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Original Drug
Generic Drug

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Vanda Pharmaceuticals
Teva Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tasimelteon market?

What factors are driving Tasimelteon market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tasimelteon market opportunities vary by end market size?

How does Tasimelteon break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

82 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Tasimelteon by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Tasimelteon by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.